ARTICLE | Finance

Banker tracks

Biotech investor, banker and analyst personnel changes

March 29, 2010 7:00 AM UTC

Marc Grasso joined UBS's healthcare banking group as managing director. He was managing director and head of West Coast investment banking at Leerink Swann.

William Young joined Clarus Ventures as a venture partner. He was CEO at diagnostic company Monogram Biosciences Inc., which was acquired by Laboratory Corp. of America Holdings (NYSE:LH) in 2009 for $107 million. Young is chairman of Biogen Idec Inc. (NASDAQ:BIIB); a member of the board at infectious disease and gastrointestinal company Theravance Inc. (NASDAQ:THRX); and executive chairman of genomics company NanoString Technologies Inc. Clarus has $1.2 billion under management...